Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling
Caroline R. Sussman, Xiaofang Wang, Fouad T. Chebib, et al.
Cellular Signalling (2020) Vol. 72, pp. 109649-109649
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
Roman‐Ulrich Müller, A. Lianne Messchendorp, Henrik Birn, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 5, pp. 825-839
Open Access | Times Cited: 96
A methionine-Mettl3-N-methyladenosine axis promotes polycystic kidney disease
Harini Ramalingam, Sonu Kashyap, Patricia Cobo-Stark, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1234-1247.e7
Open Access | Times Cited: 68
Signal transduction in primary cilia – analyzing and manipulating GPCR and second messenger signaling
Dagmar Wachten, David U. Mick
Pharmacology & Therapeutics (2021) Vol. 224, pp. 107836-107836
Open Access | Times Cited: 52
A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation
Jan N. Hansen, Fabian Kaiser, Philipp Leyendecker, et al.
EMBO Reports (2022) Vol. 23, Iss. 8
Open Access | Times Cited: 31
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors
András Dávid Tóth, Gábor Turu, László Hunyady
Nature Reviews Nephrology (2024) Vol. 20, Iss. 11, pp. 722-741
Closed Access | Times Cited: 4
Renal ciliopathies
Laura A. Devlin, Rebecca Marie Dewhurst, Praveen Dhondurao Sudhindar, et al.
Current topics in developmental biology/Current Topics in Developmental Biology (2025)
Closed Access
Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances
Abdul Hamid Borghol, Mikhail D. Antoun, Christian Hanna, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease
Xuewen Song, Evelyn Tsakiridis, Gregory R. Steinberg, et al.
Cellular Signalling (2020) Vol. 73, pp. 109704-109704
Open Access | Times Cited: 28
Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis
Marijn Stokman, Sophie Saunier, Alexandre Benmerah
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential
Yuting Sun, De Jin, Ziwei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194967-194967
Open Access | Times Cited: 10
Repurposing small molecules for nephronophthisis and related renal ciliopathies
Alexandre Benmerah, Luis Briseño-Roa, Jean‐Philippe Annereau, et al.
Kidney International (2023) Vol. 104, Iss. 2, pp. 245-253
Open Access | Times Cited: 9
Polycystic Liver Disease: Advances in Understanding and Treatment
Tatyana V. Masyuk, Anatoliy I. Masyuk, Nicholas F. LaRusso
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 251-269
Open Access | Times Cited: 23
Local cyclic adenosine monophosphate signalling cascades—Roles and targets in chronic kidney disease
Anastasiia Sholokh, Enno Klußmann
Acta Physiologica (2021) Vol. 232, Iss. 1
Open Access | Times Cited: 18
AQP2 trafficking in health and diseases: an updated overview
Mariangela Centrone, Marianna Ranieri, Annarita Di Mise, et al.
The International Journal of Biochemistry & Cell Biology (2022) Vol. 149, pp. 106261-106261
Closed Access | Times Cited: 13
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
Xia Zhou, Vicente E. Torres
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
Cross-Species Insights into Autosomal Dominant Polycystic Kidney Disease: Provide an Alternative View on Research Advancement
Jianing Luo, Yuan Zhang, Sakthidasan Jayaprakash, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5646-5646
Open Access | Times Cited: 2
Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease
Philip W. Brownjohn, Azedine Zoufir, Daniel J. O’Donovan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
Dustin T. Nguyen, Emily K. Kleczko, Nidhi Dwivedi, et al.
JCI Insight (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
The role of N-methyladenosine modification in acute and chronic kidney diseases
Saiqi Qi, Jie Song, Linjun Chen, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Pre‐clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease
Annarita Di Mise, Xiaofang Wang, Hong Ye, et al.
The FASEB Journal (2021) Vol. 35, Iss. 10
Open Access | Times Cited: 14
Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation
Julia Katharina Scholz, Andre Kraus, Dominik Lüder, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104359-104359
Open Access | Times Cited: 8
Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease
Chao Zhang, Michael Rehman, Xin Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View
Matteo Guarnaroli, Flavia Padoan, Cristiano Fava, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1823-1823
Open Access | Times Cited: 1
Cyclic Adenosine Monophosphate Signaling in Chronic Kidney Disease: Molecular Targets and Therapeutic Potentials
Charlotte Delrue, Reinhart Speeckaert, Rafael Noal Moresco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9441-9441
Open Access | Times Cited: 1
Activation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo
Qingfeng Fan, Mohamad Hadla, Zack Peterson, et al.
Kidney360 (2024) Vol. 5, Iss. 11, pp. 1601-1612
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top